The present invention relates to a novel antitumor agentcontaining a compound that inhibits binding between acetylatedhistone and a bromodomain-containing protein, preferably athienotriazolodiazepine compound represented by the followingformula (I)(see formula I)wherein each symbol is as defined in the description, or apharmaceutically acceptable salt thereof or a hydrate orsolvate as an active ingredient.
